133 related articles for article (PubMed ID: 37317716)
1. Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study.
Hwa Lee S; Ung Ha G; Ji Lee H; Yun Chung H; Huh S; Ha DL; Duck Park K; Hyun Jang Y; Ju Lee W; Lee SJ; Young Kim J
Indian J Dermatol Venereol Leprol; 2023 May; ():1-7. PubMed ID: 37317716
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of microsatellites in melanoma and implications in the American Joint Committee on Cancer classification system: A cohort study.
Riquelme-Mc Loughlin C; Sandoval-Clavijo A; Blanco de Tord M; Boada A; Alos L; García A; Carrera C; Malvehy J; Puig S; Toll A; Podlipnik S
J Am Acad Dermatol; 2023 Feb; 88(2):338-347. PubMed ID: 36265824
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
5. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
[TBL] [Abstract][Full Text] [Related]
6. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
7. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
[TBL] [Abstract][Full Text] [Related]
9. Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal study.
Tedman AJ; Liyanage UE; Chong S; Rowe C; von Schuckmann LA; Malt M; Green AC; Smithers BM; Khosrotehrani K
Australas J Dermatol; 2023 Feb; 64(1):e34-e40. PubMed ID: 36651479
[TBL] [Abstract][Full Text] [Related]
10. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
[TBL] [Abstract][Full Text] [Related]
12. A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
Hynes MC; Nguyen P; Groome PA; Asai Y; Mavor ME; Baetz TD; Hanna TP
BMC Cancer; 2022 Jul; 22(1):720. PubMed ID: 35778691
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
[TBL] [Abstract][Full Text] [Related]
14. Need to restage Korean melanoma patients following publication of the 8th edition of the American Joint Committee on Cancer staging manual.
Lee HJ; Park KD; Jang YH; Lee WJ; Lee SJ; Kim JY
Indian J Dermatol Venereol Leprol; 2022; 88(3):332-336. PubMed ID: 34491680
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
[TBL] [Abstract][Full Text] [Related]
16. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
17. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
Paver EC; Ahmed T; Burke H; Saw RPM; Stretch JR; Spillane AJ; Shannon KF; Vergara IA; Elder DE; Lo SN; Thompson JF; Scolyer RA
JAMA Dermatol; 2023 Dec; 159(12):1359-1367. PubMed ID: 37910123
[TBL] [Abstract][Full Text] [Related]
19. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
20. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
